News and Comments


Prohost Biotech - Monday, July 29, 2013

Elan is Taken over by Perrigo in a transaction that involves cash and shares of Perrigo.  For the details of the transaction, the press release and the PDF presentation by the New Perrigo Prohost subscribers can click on TODAY'S HIGHLIGHTS at this Website. 

This transaction was predictable. Congratulation for Prohost subscribers who kept the stock even during the time when the stock had tumbled under tremendous pressure by the market evaluators.  

FORWARD-LOOKING: Material presented here is for informational purposes only. Nothing in this article should be taken as a solicitation to purchase or sell securities. Before buying or selling any stock you should do your own research and reach your own conclusion. Further, these are our 'opinions' and we may be wrong. We may have positions in securities mentioned in this article. You should take this into consideration before acting on any advice given in this article. If this makes you uncomfortable, then do not listen to our thoughts and opinions. The contents of this article do not take into consideration your individual investment objectives so consult with your own financial adviser before making an investment decision. Investing includes certain risks including loss of principal.

Post has no comments.
Post a Comment

Captcha Image

Trackback Link
Post has no trackbacks.

Recent Postings



Intermune (ITMN) BIOMARIN (BMRN) ADVENTRIX (ANX) Roche (RHHBY) ACADIA (ACAD) Prolor Biotech (PBTH) Micromet (MITI) Human Longevity (HLI) ABBVIE (ABBV) Dendreon (DNDN) Multiple Myeloma REGULUS (RGLS) Spike Therapeutics (ONCE) Editas (EDIT) Regeneron (REGN) RenenxBio (RGNX) GUARDIAN HEALTH Gilead (GILD) Agenus (AGEN) Sanofi-Aventis (SAN) Tysabri Intercept (ICPT) Auspex (ASPX) VANDA (VNDA) JOUNCE THERAPEUTICS (JNCE) galapagos (GLPG) HALOZYME (HALO) Theravance (THRX) CompuGen (CGEN) Anadys (ANDS) PORTOLA (PTLA) SERES THERAPEUTICS (MCRB) Sarepta (SRPT) Ocular Therapeutix (OCUL) SUNESIS PHARMACEUTICALS (SNSS) Prosensa (RNA) AstraZeneca (AZN) Sangamo (SGMO) Agenus (AGEN ARGOS (ARGS) Elan (ELN) Trastuzumab-DM1 Advaxis (ADXS) Aimmune Therapeutics (AIMT) INNOVIVA (INVA) Jazz Pharmaceuticals (JAZZ) Xoma (XOMA) Onyx (ONXX) Telaprevir Ziofpharm (ZIOP) ARCA (ABIO) NEKTAR (NKTR)) Genentech Benlysta (belimumab) Human Genome Sciences (HGSI) Sanofi (SNA) Incyte (INCY) Seattle Genetics (SGEN) MODERNA Sequenom (SQNM) Dynavax (DVAX) Cytokinetics (CYTK) Abbott Laboratories (ABT) Vertex (VRTX) SYNTA (SNTA) Alnylam (ALNY) ZALTRAP™ Idenix (IDIX) Intrexon (XON) Anacor (ANAC) Endometrial Cancer Galena (GALE) ImmunoGen (IMGN) JUNO (JUNO) NOVOCURE (NVCR) Zerenex KITE (KITE) KERYX (KERX) GlaxoSmithKline (GSK) Theravance Bio Pharma (TBPH) Rapamune AERIE PHARMACEUTICALS IDERA (IDRA) Ridaforolimus Ariad (ARIA) OSI (OSIP) Revlimid (lenolidamide) OncoCyte (OCX) Global Cell Therapeutics (GBT) NANTKWEST (NK) Valeant Pharmaceuticals International (VRX) Amgen (AMGN) PTC Therapeutics (PTCT) CRISPR Therapeutics (CRSP) Illumina (ILMN) C4 Therapeutics AGOS (ARGS) CEMPRA (CEMP) Alder Biopharmaceuticals (ALDR) Bellicum (BLCM) TOKAI (TKAOI) Ionis (IONS) Mirati Therapeutics (MRTX) Pluristem (PSTI) Biocryst (BCRX) Adaptimmune (ADAP) LEXICON (LXRX) Velcade (bortezomib) Roche (ROCHE) Sanofi (SNY) Exelixis (EXEL) Herceptin Bristol-Myers Squibb (BMY) Array Pharmaceuticals (ARRY) Inovio (INO) Biogen Idec (BIIB) Merck (MRK) Vitae Pharmaceuticals (VTAE) ISIS (ISIS)